These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29950406)

  • 21. Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation.
    Keyes LR; Bego MG; Soland M; St Jeor S
    J Gen Virol; 2012 Apr; 93(Pt 4):722-732. PubMed ID: 22238232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric Oxide Circumvents Virus-Mediated Metabolic Regulation during Human Cytomegalovirus Infection.
    Mokry RL; Schumacher ML; Hogg N; Terhune SS
    mBio; 2020 Dec; 11(6):. PubMed ID: 33323506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug targets in cytomegalovirus infection.
    Andrei G; De Clercq E; Snoeck R
    Infect Disord Drug Targets; 2009 Apr; 9(2):201-22. PubMed ID: 19275707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human cytomegalovirus microRNA miR-US25-1-5p inhibits viral replication by targeting multiple cellular genes during infection.
    Jiang S; Qi Y; He R; Huang Y; Liu Z; Ma Y; Guo X; Shao Y; Sun Z; Ruan Q
    Gene; 2015 Oct; 570(1):108-14. PubMed ID: 26055091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.
    Ahn JH; Hayward GS
    Virology; 2000 Aug; 274(1):39-55. PubMed ID: 10936087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral DNA Sensors IFI16 and Cyclic GMP-AMP Synthase Possess Distinct Functions in Regulating Viral Gene Expression, Immune Defenses, and Apoptotic Responses during Herpesvirus Infection.
    Diner BA; Lum KK; Toettcher JE; Cristea IM
    mBio; 2016 Nov; 7(6):. PubMed ID: 27935834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host cell nucleolin is required to maintain the architecture of human cytomegalovirus replication compartments.
    Strang BL; Boulant S; Kirchhausen T; Coen DM
    mBio; 2012; 3(1):. PubMed ID: 22318319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells.
    Bronzini M; Luganini A; Dell'Oste V; De Andrea M; Landolfo S; Gribaudo G
    J Virol; 2012 Jun; 86(12):6875-88. PubMed ID: 22496217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection.
    Luo MH; Rosenke K; Czornak K; Fortunato EA
    J Virol; 2007 Feb; 81(4):1934-50. PubMed ID: 17151099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
    Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
    Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Imaging Approach for Single-Cell Real-Time Analysis of Oncolytic Virus Replication and Efficacy in Cancer Cells.
    Quillien L; Top S; Kappler-Gratias S; Redouté A; Dusetti N; Quentin-Froignant C; Lulka H; Camus-Bouclainville C; Buscail L; Gallardo F; Bertagnoli S; Cordelier P
    Hum Gene Ther; 2021 Feb; 32(3-4):166-177. PubMed ID: 33504260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contributions of the Human Cytomegalovirus U
    Monaghan M; Munger J
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells.
    Murphy EA; Streblow DN; Nelson JA; Stinski MF
    J Virol; 2000 Aug; 74(15):7108-18. PubMed ID: 10888651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
    Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection.
    Rosenke K; Samuel MA; McDowell ET; Toerne MA; Fortunato EA
    Virology; 2006 Apr; 348(1):19-34. PubMed ID: 16455125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects by combination of ganciclovir and tricin on human cytomegalovirus replication in vitro.
    Yamada R; Suda H; Sadanari H; Matsubara K; Tuchida Y; Murayama T
    Antiviral Res; 2016 Jan; 125():79-83. PubMed ID: 26640224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10).
    Ahn JH; Jang WJ; Hayward GS
    J Virol; 1999 Dec; 73(12):10458-71. PubMed ID: 10559364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New cell-based indicator assays for the detection of human cytomegalovirus infection and screening of inhibitors of viral immediate-early 2 protein activity.
    Luganini A; Caposio P; Mondini M; Landolfo S; Gribaudo G
    J Appl Microbiol; 2008 Dec; 105(6):1791-801. PubMed ID: 19120629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection of endotheliotropic human cytomegalovirus of trabecular meshwork cells.
    Shimizu D; Miyazaki D; Shimizu Y; Hosogai M; Kosugi I; Inoue Y
    Jpn J Ophthalmol; 2018 Nov; 62(6):667-676. PubMed ID: 30191418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of ganciclovir-resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine).
    Murayama T; Yamaguchi N; Iwamoto K; Eizuru Y
    Antivir Chem Chemother; 2006; 17(1):11-6. PubMed ID: 16542001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.